Clinical Trial Results:
INVESTIGATOR-INITIATED SINGLE BLIND, TWO-ARMED, RANDOMIZED PHASE 3 CLINICAL TRIAL TO COMPARE EFFICACY OF 5% MINOXIDIL TOPICAL FOAM (5% MTF) ONCE DAILY VERSUS 2% MINOXIDIL TOPICAL SOLUTION (2% MTS) TWICE DAILY IN APPLICATION ON FEMALES WITH SLIGHTLY TO MODERATE ANDROGENETIC ALOPECIA CONCERNING HAIR VOLUME
Investigator-initiierte einfach verblindete, zweiarmige, randomisierte klinische Phase 3 Studie zum Nachweis der Wirksamkeit auf das Haarvolumen von 5%igen Minoxidil 1x tgl. versus 2%igem Minoxidil 2x tgl. bei Frauen mit leichter bis mäßiger androgenetischer Alopezie
Summary
|
|
EudraCT number |
2008-001770-33 |
Trial protocol |
DE |
Global completion date |
28 Feb 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Aug 2020
|
First version publication date |
29 Aug 2020
|
Other versions |
|
Summary report(s) |
Link-to-publication-PORTAL-study_2008-001770-33 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.